Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.
The FDA has approved its supplemental New Drug Application for Wakix tablets for the treatment of excessive daytime sleepiness in pediatric patients aged 6 years and older with narcolepsy.